|
|
A Shocking New Discovery to Treat Erectile Dysfunction
Wednesday, 11.25.2009, 01:15pm (GMT-4)
A new treatment has been discovered to help treat erectile dysfunction,
however, the men might wince at the thought of this idea. Researchers
from Israel have reported promising preliminary results from using
low-intensity shock wave therapy to help treat vasculogenic erectile
dysfunction (ED).
In fact, 15 out of the 20 patients who
suffered from mild or moderate ED who have been treated so far had a
significant improvement with their erectile function, and in most cases
were able to discontinue treatment with phosphodiesterase-5 (PDE-5)
inhibitors.
Yoram Vardi, M.D., chief of the neuro-urology unit
at the Rambam Medical Center in Haifa, presented the recent findings at
the annual meeting of the European Society for Sexual Medicine. He
explained that the low-energy shock wave therapy is being increasingly
used to help induce regeneration of small coronary vessels in patients
that have angina and who are not suitable for angioplasty or coronary
surgery.
The participants in the trial had a score of 12 to 20
on the Erectile Function domain of the International Index of Erectile
Function (IIEF-ED) and abnormal nocturnal penile tumescence (NPT). In
all of the cases for the study, ED had a vascular origin and the mean
of the duration of ED was 35 months.
During each of the
treatment sessions, the low-energy shock wave therapy was applied on
the penile shaft and crus for approximately three minutes in each of
the five anatomical sites. The shock waves are one-tenth the level of
intensity as the shock waves that are used to pulverize kidney stones.
The men underwent a three-week course of two weekly treatment sessions
and then a second identical round of therapy that started three weeks
later. The erectile dysfunction was assessed at the time of enrollment
and then four weeks after the end of their treatment.
Vardi
said, “The protocol used to enhance vasculogenesis of the ischemic
heart is the same one we used to treat ED.” The results showed that the
IIEF-ED score improved by more than 5 points in 15 patients, which is
approximately 75 percent of the group. Seven out of the 20 patients, or
approximately 35 percent, showed an improvement of more than 10 points
on the scale.
The six-month follow up data showed that 12 out of the 15
patients who improved significantly with the shock treatment said that
they no longer needed to use the PDE-5 inhibitors to help treat their
condition.
The scores on several other validated ED
questionnaires such as Self-Esteem and Relationship Questionnaire,
Quality of Erection Questionnaire, and the Erectile Dysfunction
Inventory of Treatment Satisfaction also showed significant
improvement.
The study analysis also showed a significant improvement
in the baseline and maximal flow values on a penile endothelial
function test.
Dr. Vardi stated, “We are very excited by our
findings but it’s important to emphasize that they are preliminary and
that further evaluation is needed using sham control and long-term
follow-up.
And what has been especially gratifying is that patients
have told us that they are very pleased with the results and they tell
us that they are again having morning erections and they can perform
better.”
By Allie Montgomery
|
|
| February 2012 |
| Su |
Mo |
Tu |
We |
Th |
Fr |
Sa |
| |
|
|
1 |
2 |
3 |
4 |
| 5 |
6 |
7 |
8 |
9 |
10 |
11 |
| 12 |
13 |
14 |
15 |
16 |
17 |
18 |
| 19 |
20 |
21 |
22 |
23 |
24 |
25 |
| 26 |
27 |
28 |
29 |
|
|
|
|
| |
|
|
The H1N1 virus, commonly known as swine flu virus, could infect between 30 percent and 50 percent of the American population during the fall and winter and lead to as many as 1.8 million U.S. hospital admissions, the President's Council of Advisors on Science and Technology reported.
The report says 30,000 to 90,000 deaths are projected as part of a "plausible scenario" involving large outbreaks at schools, inadequate antiviral supplies and the virus peaking before vaccinations have time to be effective.
More on the story
|
|
|
|